RU2011105636A - METHOD FOR COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER II AND III STAGE WITH PRE- AND POSTOPERATIVE CHEMOTHERAPY - Google Patents
METHOD FOR COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER II AND III STAGE WITH PRE- AND POSTOPERATIVE CHEMOTHERAPY Download PDFInfo
- Publication number
- RU2011105636A RU2011105636A RU2011105636/15A RU2011105636A RU2011105636A RU 2011105636 A RU2011105636 A RU 2011105636A RU 2011105636/15 A RU2011105636/15 A RU 2011105636/15A RU 2011105636 A RU2011105636 A RU 2011105636A RU 2011105636 A RU2011105636 A RU 2011105636A
- Authority
- RU
- Russia
- Prior art keywords
- chemotherapy
- courses
- lung cancer
- small cell
- cell lung
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ комбинированного лечения немелкоклеточного рака легкого II и III стадии с пред- и послеоперационной химиотерапией, включающий проведение неоадъювантной химиотерапии с применением карбоплатина и последующее радикальное хирургическое вмешательство, отличающийся тем, что проводят 3 курса неоадъювантной химиотерапии путем внутривенного введения иринотекана в дозе 100 мг/м2 в течение 2-х ч на 1 и 8 дни цикла, во 2 день, через 20 ч после введения иринотекана внутривенно капельно вводят карбоплатин в дозе по AUC 6, интервал между курсами химиотерапии составляет 25 дней, далее, в послеоперационном периоде на 18 сутки дополнительно проводят адъювантную химиотерапию по вышеописанной схеме, в количестве 2-х курсов. A method for the combined treatment of stage II and III non-small cell lung cancer with pre- and postoperative chemotherapy, including neoadjuvant chemotherapy using carboplatin and subsequent radical surgery, characterized in that 3 courses of neoadjuvant chemotherapy are carried out by intravenous administration of irinotecan at a dose of 100 mg / m2 for 2 hours on days 1 and 8 of the cycle, on day 2, 20 hours after the administration of irinotecan, carboplatin is administered intravenously in a dose of AUC 6, the interval between chemotherapy courses FIPA is 25 days, then, postoperative day 18 further adjuvant chemotherapy is carried out by the above scheme, in an amount of 2 courses.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011105636/15A RU2492855C2 (en) | 2011-02-15 | 2011-02-15 | Method for combination therapy of stage ii and iii non-small cell lung cancer with pre- and postoperative chemotherapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011105636/15A RU2492855C2 (en) | 2011-02-15 | 2011-02-15 | Method for combination therapy of stage ii and iii non-small cell lung cancer with pre- and postoperative chemotherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011105636A true RU2011105636A (en) | 2012-08-20 |
RU2492855C2 RU2492855C2 (en) | 2013-09-20 |
Family
ID=46936335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011105636/15A RU2492855C2 (en) | 2011-02-15 | 2011-02-15 | Method for combination therapy of stage ii and iii non-small cell lung cancer with pre- and postoperative chemotherapy |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2492855C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2593342C1 (en) * | 2015-03-26 | 2016-08-10 | Федеральное государственное бюджетное научное учреждение "Томский научно-исследовательский институт онкологии" (Томский НИИ онкологии) | Method of combination treatment of non-small cell lung cancer stage 1b-111 with customization of adjuvant chemotherapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2340336C1 (en) * | 2007-05-02 | 2008-12-10 | Государственное учреждение научно-исследовательский институт онкологии Томского Научного центра Сибирского отделения Российской академии медицинских наук (ГУ НИИ онкологии ТНЦ СО РАМН) | Method of combined treatment of non-small cell cancer of lung of iii stage |
PE20091180A1 (en) * | 2007-12-27 | 2009-08-26 | Infinity Pharmaceuticals Inc | THERAPEUTIC TREATMENTS AGAINST CANCER |
RU2367436C1 (en) * | 2008-05-26 | 2009-09-20 | Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН | Lung cancer therapy |
-
2011
- 2011-02-15 RU RU2011105636/15A patent/RU2492855C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2492855C2 (en) | 2013-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018120318A (en) | IMIDAZO [4,5-c] QUINOLIN-2-ONE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER | |
EA201270247A1 (en) | METHODS OF APPLICATION OF C-METER-MODULATORS | |
EA201000091A1 (en) | DERIVATIVES OF MORFOLINOPYRIMIDINE USED IN DISEASES ASSOCIATED WITH mTOR KINASE AND / OR PI3K | |
JP2014528423A5 (en) | ||
RU2014117666A (en) | TREATMENT OF Pancreatic cancer and non-small cell lung cancer with ATR inhibitors | |
JP2012180381A5 (en) | ||
EA201490472A1 (en) | COMBINED CANCER THERAPY FOR HSP90 INHIBITOR AND ANTIMETABOLITIS | |
MD4643B1 (en) | Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same | |
MY169330A (en) | Method for inhibition of deubiquitinating activity | |
RU2014141365A (en) | METHOD FOR INTRODUCING ANTITUMOR AGENT | |
RU2016136504A (en) | APPLICATION OF ERIBULIN AND mTOR INHIBITORS AS A COMBINED THERAPY FOR TREATMENT OF MALIGNANT NORMAL FORMATION | |
JP2012522841A5 (en) | ||
MX2021014523A (en) | Methods of treating cholangiocarcinoma. | |
RU2010118082A (en) | METHOD FOR TREATING RED FLAT | |
RU2011105636A (en) | METHOD FOR COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER II AND III STAGE WITH PRE- AND POSTOPERATIVE CHEMOTHERAPY | |
RU2010139840A (en) | COMBINATION OF ANTI-CANCER AGENTS | |
RU2013142014A (en) | GAMMA SECRETASE INHIBITOR METHOD | |
RU2010127350A (en) | METHOD FOR TREATMENT WITH BLADDER CANCER | |
RU2010133699A (en) | METHOD FOR COMBINED TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY | |
RU2008129232A (en) | METHOD FOR TREATING LUNG TUBERCULOSIS IN HIV-INFECT PATIENTS | |
RU2007115511A (en) | METHOD FOR COMBINED TREATMENT OF LOCAL NON-SMALL CELL LUNG CANCER | |
RU2011108787A (en) | METHOD FOR TREATING PATIENTS WITH RED PLANE | |
RU2012156689A (en) | METHOD FOR TREATING AN ENDOGENOUS INTOXICATION SYNDROME DUE TO HYPERPROTEOLYSIS | |
RU2009124823A (en) | METHOD FOR TREATING A PATIENT WITH CHRONIC Brucellosis | |
RU2011115020A (en) | METHOD FOR TREATING PATIENTS WITH ERYTHEMATOSIS-PAPULOUS FORM OF ROSATSEA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20130326 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130811 |